AstraZeneca PLC (AZN) Release: Results From Phase III Studies of Naloxegol for Treatment of Opioid-Induced Constipation Presented at Digestive Disease Week 2013
5/21/2013 10:57:00 AM
More...
|
AstraZeneca PLC (AZN) Closes in on Site for New $500 Million Home in Cambridge
5/21/2013 8:16:00 AM
More...
|
AstraZeneca PLC (AZN) Release: Results from Phase III Studies of Naloxegol for Treatment of Opioid-Induced Constipation Presented at Digestive Disease Week 2013
5/21/2013 7:51:49 AM
More...
|
AstraZeneca PLC (AZN) Advances Three Cancer Drugs Into Late-Stage Trials
5/16/2013 7:57:17 AM
More...
|
AstraZeneca PLC (AZN), Cubist Pharmaceuticals, Inc. (CBST), Astellas Pharma Inc. (YPH.BE) Said to Make Bids for Optimer Pharmaceuticals, Inc. (OPTR)
5/15/2013 8:19:07 AM
More...
|
AstraZeneca PLC (AZN) and Bristol-Myers Squibb Company (BMY) Receive Award from Major Medical Association
5/7/2013 11:06:28 AM
More...
|
VIVUS, Inc. (VVUS) Announces Richard Fante, Former President U.S. and CEO North America, AstraZeneca PLC (AZN), to Serve as Senior Advisor
5/7/2013 9:34:15 AM
More...
|
Redx Pharma Creates 120 New Jobs at Site Being Vacated by AstraZeneca PLC (AZN)
5/7/2013 7:26:31 AM
More...
|
Bristol-Myers Squibb Company (BMY), AstraZeneca PLC (AZN) Release: Sub-Group Analysis Shows Investigational Metreleptin Treatment Demonstrated Reductions in HbA1c, Triglycerides and Liver Function Tests in Pediatric Patients With Lipodystrophy During a 12-Month Period
5/6/2013 10:06:55 AM
More...
|
Unions Fight AstraZeneca PLC (AZN) Plans to Move R&D Base South
4/30/2013 8:08:51 AM
More...
|
|